Search research articles
Contact Us
Filters
Showing results (11-20 of 654) with videos related to
Page
of 66
Sort By:
The Journal of Ambulatory Care Management
|
May 29, 2019
Ten Things I Learned From Rob During a Lifetime of Health Care Advocacy
Michael Miller
The Journal of Ambulatory Care Management
|
May 29, 2019
Can We Find a Path Between Medicare for All and Building on the ACA?
Michael Miller
Future Cardiology
|
September 17, 2019
Icosapent ethyl for hypertriglyceridemia: insights from the REDUCE-IT Trial
Michael Miller
Journal of Wound Care
|
January 14, 2012
Literary lightning (in a bottle)
Michael Miller
The New England Journal of Medicine
|
August 17, 2004
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
Michael Miller
Journal of Substance Abuse Treatment
|
February 24, 2006
The seductiveness of evidence
Michael Miller
Journal of HIV Therapy
|
April 9, 2008
Resistance to integrase inhibitors
Michael Miller
Journal of Wound Care
|
July 14, 2017
Expertise by examination: has the experiment failed?
Michael Miller
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 26, 2017
Apolipoprotein C-III: The Small Protein With Sizeable Vascular Risk
Michael Miller
Preventive Cardiology
|
January 12, 2007
Optimal treatment of dyslipidemia in high-risk patients: intensive statin treatment or combination therapy?
Michael Miller
Page
of 66
Search research articles
Search
Showing results (11-20 of 654) with videos related to
Sort By:
Page
of 66
The Journal of Ambulatory Care Management
|
May 29, 2019
Ten Things I Learned From Rob During a Lifetime of Health Care Advocacy
Michael Miller
The Journal of Ambulatory Care Management
|
May 29, 2019
Can We Find a Path Between Medicare for All and Building on the ACA?
Michael Miller
Future Cardiology
|
September 17, 2019
Icosapent ethyl for hypertriglyceridemia: insights from the REDUCE-IT Trial
Michael Miller
Journal of Wound Care
|
January 14, 2012
Literary lightning (in a bottle)
Michael Miller
The New England Journal of Medicine
|
August 17, 2004
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
Michael Miller
Journal of Substance Abuse Treatment
|
February 24, 2006
The seductiveness of evidence
Michael Miller
Journal of HIV Therapy
|
April 9, 2008
Resistance to integrase inhibitors
Michael Miller
Journal of Wound Care
|
July 14, 2017
Expertise by examination: has the experiment failed?
Michael Miller
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 26, 2017
Apolipoprotein C-III: The Small Protein With Sizeable Vascular Risk
Michael Miller
Preventive Cardiology
|
January 12, 2007
Optimal treatment of dyslipidemia in high-risk patients: intensive statin treatment or combination therapy?
Michael Miller
Page
of 66